Évaluation de la survie globale des patients présentant un adénocarcinome de stade avancé, selon l’existence de mutations EGFR dans 5 centres picards
Sign Up to like & getrecommendations! Published in 2017 at "Revue Des Maladies Respiratoires"
DOI: 10.1016/j.rmr.2016.10.476
Abstract: Introduction L’adenocarcinome est le type de cancer pulmonaire le plus frequent. La plupart du temps decouvert au stade avance, il est par consequent de mauvais pronostic. La recherche d’anomalies moleculaires comme la mutation du recepteur… read more here.
Keywords: mutation egfr; les patients; survie globale; etait ... See more keywords
Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR
Sign Up to like & getrecommendations! Published in 2017 at "ESMO Open"
DOI: 10.1136/esmoopen-2016-000104
Abstract: Osimertinib is a third-generation tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR) that has been approved for the treatment of metastatic non-small cell lung cancer (NSCLC) positive for the secondary T790M mutation… read more here.
Keywords: t790m mutation; mutation egfr; treatment; leptomeningeal carcinomatosis ... See more keywords